Literature DB >> 24280248

Assessing the need for and acceptability of a free-of-charge postpartum HPV vaccination program.

Abbey B Berenson1, Eneida Male2, Toy G Lee2, Alan Barrett3, Kwabena O Sarpong4, Richard E Rupp4, Mahbubur Rahman2.   

Abstract

OBJECTIVE: Human papillomavirus (HPV) vaccine uptake rate among young adult US women was only 23% in 2010. One way to improve this low rate is to administer the vaccine postpartum. We examined whether this population requires vaccination and whether they would be agreeable to receiving it free of charge after delivery. STUDY
DESIGN: Women 26 years of age or younger seeking prenatal care in publicly funded clinics in southeast Texas were interviewed in 2012 regarding their HPV vaccination status, barriers to vaccination, and whether they would be willing to receive this vaccine postpartum if offered free of charge. Medical charts were reviewed to extract additional information.
RESULTS: Overall, 13.0% (65 of 500) stated they had initiated and 7.6% (38 of 500) completed the 3-dose vaccine series. Ethnic differences were noted with 21.0% of non-Hispanic whites, 14.6% of blacks, and 9.3% of Hispanics (P = .002) initiating the vaccine and 13.5%, 7.8%, and 5.2% (P = .006) competing all 3 doses, respectively. Lowest initiation (4.2%) and completion (1.4%) rates were observed among recently immigrated Hispanic women. Those who had not graduated from high school and older women were less likely to have been vaccinated. Almost 83% of those who had not received any HPV doses or completed the series were willing to receive the injection free of charge in the hospital after their delivery.
CONCLUSION: HPV vaccine uptake rates are very low among women receiving prenatal care in southeast Texas. Offering this vaccine free of charge to postpartum women could be an effective strategy in this population because 5 of 6 women favored receiving it in this setting.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  HPV; correlates; human papillomavirus; postpartum; race/ethnicity; vaccine

Mesh:

Substances:

Year:  2013        PMID: 24280248      PMCID: PMC3995166          DOI: 10.1016/j.ajog.2013.11.036

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

1.  Acceptance of hepatitis B vaccination by pregnant adolescents.

Authors:  Marilyn Stringer; Sarah J Ratcliffe; Robert Gross
Journal:  MCN Am J Matern Child Nurs       Date:  2006 Jan-Feb       Impact factor: 1.412

2.  Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.

Authors: 
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

3.  ACOG committee opinion no. 558: Integrating immunizations into practice.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-04       Impact factor: 7.661

4.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Authors:  Luisa L Villa; Ronaldo L R Costa; Carlos A Petta; Rosires P Andrade; Kevin A Ault; Anna R Giuliano; Cosette M Wheeler; Laura A Koutsky; Christian Malm; Matti Lehtinen; Finn Egil Skjeldestad; Sven-Eric Olsson; Margareta Steinwall; Darron R Brown; Robert J Kurman; Brigitte M Ronnett; Mark H Stoler; Alex Ferenczy; Diane M Harper; Gretchen M Tamms; Jimmy Yu; Lisa Lupinacci; Radha Railkar; Frank J Taddeo; Kathrin U Jansen; Mark T Esser; Heather L Sings; Alfred J Saah; Eliav Barr
Journal:  Lancet Oncol       Date:  2005-05       Impact factor: 41.316

5.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger
Journal:  MMWR Recomm Rep       Date:  2007-03-23

6.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

7.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

Review 8.  Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.

Authors:  F Xavier Bosch; Ann N Burchell; Mark Schiffman; Anna R Giuliano; Silvia de Sanjose; Laia Bruni; Guillermo Tortolero-Luna; Susanne Kruger Kjaer; Nubia Muñoz
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

9.  Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.

Authors:  Elmar A Joura; Sepp Leodolter; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Laura A Koutsky; Suzanne M Garland; Diane M Harper; Grace W K Tang; Daron G Ferris; Marc Steben; Ronald W Jones; Janine Bryan; Frank J Taddeo; Oliver M Bautista; Mark T Esser; Heather L Sings; Micki Nelson; John W Boslego; Carlos Sattler; Eliav Barr; Jorma Paavonen
Journal:  Lancet       Date:  2007-05-19       Impact factor: 79.321

Review 10.  Safety of human papillomavirus vaccines: a review.

Authors:  Kristine K Macartney; Clayton Chiu; Melina Georgousakis; Julia M L Brotherton
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

View more
  6 in total

1.  Factors Associated with HPV Vaccine Awareness in a Population-Based Sample of Hispanic Women in Puerto Rico.

Authors:  J Romaguera; D Caballero-Varona; G Tortolero-Luna; E Marrero; E Suárez; C M Pérez; C Muñoz; J Palefsky; A P Ortiz
Journal:  J Racial Ethn Health Disparities       Date:  2015-07-14

2.  Improving Human Papillomavirus (HPV) Vaccination in the Postpartum Setting.

Authors:  Reni Soon; Stephen Sung; May Rose Dela Cruz; John J Chen; Mark Hiraoka
Journal:  J Community Health       Date:  2017-02

3.  A human papillomavirus vaccination program for low-income postpartum women.

Authors:  Abbey B Berenson; Mahbubur Rahman; Jacqueline M Hirth; Richard E Rupp; Kwabena O Sarpong
Journal:  Am J Obstet Gynecol       Date:  2016-02-17       Impact factor: 8.661

4.  Low Uptake of Human Papillomavirus Vaccine Among Postpartum Women, 2006-2012.

Authors:  Kimberly A Kilfoyle; Lisa Rahangdale; Stacie B Dusetzina
Journal:  J Womens Health (Larchmt)       Date:  2016-07-22       Impact factor: 2.681

5.  Inpatient Immunization With HPV Vaccine: A Qualitative Study With Postpartum Women.

Authors:  Lital Avni-Singer; Carlos R Oliveira; Ashlynn Torres; Eugene D Shapiro; Linda M Niccolai; Sangini S Sheth
Journal:  Womens Health Issues       Date:  2021-03-11

6.  Factors affecting HPV vaccine acceptance in west Austria: Do we need to revise the current immunization scheme?

Authors:  Wegene Borena; Anita Luckner-Hornischer; Franz Katzgraber; Dorothee Holm-von Laer
Journal:  Papillomavirus Res       Date:  2016-10-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.